Published in J Oncol on June 22, 2010
Incidence patterns and temporal trends of invasive nonmelanotic vulvar tumors in Germany 1999-2011. A population-based cancer registry analysis. PLoS One (2015) 0.86
Gynecological Cancer Age Groups at the "Dr. Salvator Vuia" Clinical Obstetrics and Gynecology Hospital during the 2000-2009 Period. Maedica (Buchar) (2011) 0.75
Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods. Cancer (2008) 2.00
New aspects of vulvar cancer: changes in localization and age of onset. Gynecol Oncol (2008) 1.80
Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstet Gynecol (2009) 1.45
Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways. Int J Gynecol Pathol (2006) 1.31
Incidence of in situ and invasive vulvar cancer in the US, 1998-2003. Cancer (2008) 1.17
Review of squamous premalignant vulvar lesions. Crit Rev Oncol Hematol (2008) 1.09
Is the incidence of invasive vulvar cancer increasing in the United States? Cancer Causes Control (2009) 1.01
Vulvar squamous cell carcinoma: guidelines for early diagnosis and treatment. Am J Obstet Gynecol (2003) 0.89
Clinicopathologic features of vulvar squamous cell carcinomas exhibiting prominent fibromyxoid stromal response. Int J Gynecol Pathol (1996) 0.86
Inactivation of the CDKN2A and the p53 tumour suppressor genes in external genital carcinomas and their precursors. Br J Dermatol (2007) 0.86
[Epidemiology of vulvar intra-epithelial neoplasias]. Gynecol Obstet Fertil (2007) 0.85
Squamous cell carcinoma of the vulva. Localization of the primary tumor and lymph node metastases. Acta Obstet Gynecol Scand (1981) 0.85
Municipal distribution of ovarian cancer mortality in Spain. BMC Cancer (2008) 0.85
A comparison of younger vs older women with vulvar cancer in the United States. Am J Obstet Gynecol (2008) 0.85
Histopathologic study of thin vulvar squamous cell carcinomas and associated cutaneous lesions: a correlative study of 48 tumors in 44 patients with analysis of adjacent vulvar intraepithelial neoplasia types and lichen sclerosus. Am J Surg Pathol (2006) 0.83
Radical vulvectomy. The decision for the incision. Cancer (1993) 0.81
Problems in the interpretation of small area analysis of epidemiological data: the case of cancer incidence in the West of Scotland. J Epidemiol Community Health (1992) 0.81
Human papillomavirus infection in squamous cell carcinoma of the vulva, in various synchronous epithelial changes and in normal vulvar skin. Gynecol Oncol (1997) 0.81
Cancer risk among residents of Rhineland-Palatinate winegrowing communities: a cancer-registry based ecological study. J Occup Med Toxicol (2008) 0.80
Angiogenesis in benign, pre-malignant and malignant vulvar lesions. Anticancer Res (2003) 0.80
Vulvar cancer in the wake of increasing incidence. Nurse Pract (2009) 0.78
[Screening strategies for vulvar preneoplastic and neoplastic lesions]. Minerva Ginecol (2000) 0.78
Invasive cancer in the vulvar region. Acta Obstet Gynecol Scand (1982) 0.78
Vulvar cancer in women less than fifty in United States, 1980-2005. Gynecol Oncol (2008) 0.78
Vulvar cancer and the need for awareness of precursor lesions. J Low Genit Tract Dis (2009) 0.77
Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol (2009) 9.27
Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG. J Clin Oncol (2006) 4.92
A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer. J Natl Cancer Inst (2003) 3.77
Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse. J Clin Oncol (2010) 3.46
Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO. J Natl Cancer Inst (2006) 1.86
Pontocerebellar hypoplasia type 1: clinical spectrum and relevance of EXOSC3 mutations. Neurology (2013) 1.61
Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse. Int J Cancer (2013) 1.27
Plasma chromogranin A as marker for survival in patients with metastatic endocrine gastroenteropancreatic tumors. Clin Gastroenterol Hepatol (2008) 1.27
Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors: a randomized trial. Clin Gastroenterol Hepatol (2005) 1.23
Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer. Clin Cancer Res (2002) 1.22
Operator-independent isotropic three-dimensional magnetic resonance imaging for morphology in congenital heart disease: a validation study. Circulation (2004) 1.22
Flow volume and shunt quantification in pediatric congenital heart disease by real-time magnetic resonance velocity mapping: a validation study. Circulation (2004) 1.20
CDKN2A germline mutations in familial pancreatic cancer. Ann Surg (2002) 1.18
Release of macrophage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection. J Virol (2002) 1.16
Rapid left-to-right shunt quantification in children by phase-contrast magnetic resonance imaging combined with sensitivity encoding (SENSE). Circulation (2003) 1.10
Cardiac function by MRI in congenital heart disease: impact of consensus training on interinstitutional variance. J Magn Reson Imaging (2009) 1.06
Vaccination of patients with advanced ovarian carcinoma with the anti-idiotype ACA125: immunological response and survival (phase Ib/II). Clin Cancer Res (2004) 0.99
VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors. Surgery (2002) 0.98
Pathologic breast conditions in childhood and adolescence: evaluation by sonographic diagnosis. J Ultrasound Med (2005) 0.90
The changing landscape of therapeutic strategies for recurrent ovarian cancer. Future Oncol (2012) 0.89
CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cells. Eur J Cancer (2011) 0.89
Accuracy of frozen section examination of testicular tumors of uncertain origin. Eur Urol (2002) 0.88
Cardiac volumetry in patients with heart failure and reduced ejection fraction: a comparative study correlating multi-slice computed tomography and magnetic resonance tomography. Reasons for intermodal disagreement. Clin Res Cardiol (2009) 0.87
Breast Centers in Germany. Breast Care (Basel) (2009) 0.87
2008 update of the guideline: early detection of breast cancer in Germany. J Cancer Res Clin Oncol (2008) 0.86
[A concept for the implementation and evaluation of the guideline "Early Detection of Breast Cancer in Germany"]. Z Arztl Fortbild Qualitatssich (2004) 0.86
Blood flow quantification in adults by phase-contrast MRI combined with SENSE--a validation study. J Cardiovasc Magn Reson (2005) 0.85
Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer. Cancer Res (2003) 0.85
Glutamate receptor GRIA3--target of CUX1 and mediator of tumor progression in pancreatic cancer. Neoplasia (2010) 0.84
Nitric oxide-dependent vasorelaxation and endothelial cell damage caused by mercury chloride. Toxicology (2003) 0.83
Combining dispositions and evaluations of vocation and job to account for counterproductive work behavior in adolescent job apprentices. J Occup Health Psychol (2007) 0.83
Valid comparisons and decisions based on clinical registers and population based cohort studies: assessing the accuracy, completeness and epidemiological relevance of a breast cancer query database. BMC Res Notes (2012) 0.83
Left ventricular volumetry in healthy children and adolescents: comparison of two different real-time three-dimensional matrix transducers with cardiovascular magnetic resonance. Eur J Echocardiogr (2009) 0.83
Tumor-suppressing pathways in cystic pancreatic tumors. Pancreas (2003) 0.82
Metaanalysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinoma. Cancer (2005) 0.82
Antineoplastic effect of immunostimulatory DNA (CpG-ODN) in a murine C57-BL6/MB-49 transitional cell carcinoma model. Anticancer Res (2004) 0.82
In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall. Anticancer Res (2009) 0.82
Effects of the tyrosine kinase inhibitor imatinib on neuroendocrine tumor cell growth. Digestion (2005) 0.82
CA19.9 and CEA in transitional cell carcinoma of the bladder: serological and immunohistochemical findings. Anticancer Res (2010) 0.82
Disruption of a nuclear NFATc2 protein stabilization loop confers breast and pancreatic cancer growth suppression by zoledronic acid. J Biol Chem (2011) 0.81
The Impact of Breast Care Nurses on Patients' Satisfaction, Understanding of the Disease, and Adherence to Adjuvant Endocrine Therapy. Breast Care (Basel) (2011) 0.80
Direct observation of microtubule pushing by cortical dynein in living cells. Mol Biol Cell (2013) 0.79
Ultrafast time-resolved contrast-enhanced 3D pulmonary venous cardiovascular magnetic resonance angiography using SENSE combined with CENTRA-keyhole. J Cardiovasc Magn Reson (2007) 0.79
Differentiation and histogenesis of syringomatous tumour of the nipple and low-grade adenosquamous carcinoma: evidence for a common origin. Histopathology (2014) 0.79
[Familial pancreatic cancer--concept for study of the National Case Collection and early diagnosis program for high risk people]. Z Arztl Fortbild Qualitatssich (2002) 0.78
Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study. Breast Cancer Res Treat (2006) 0.78
β-Catenin signaling: no relevance in Hodgkin lymphoma? Leuk Lymphoma (2011) 0.77
[Psychological distress of breast cancer patients: screening and patients' request for psycho-oncological care as indicators of health-related quality of life]. Psychother Psychosom Med Psychol (2012) 0.77
Histomorphometrical analysis of microvascular abnormalities in connective tissue diseases. Rheumatol Int (2007) 0.77
Hereditary fetal brain degeneration resembling fetal brain disruption sequence in two sibships. Am J Med Genet A (2004) 0.77
Prognostic factors of papillary renal cell carcinoma: results from a multi-institutional series after pathological review. J Urol (2009) 0.77
Myositis in a patient with large granular leukocyte leukemia. Muscle Nerve (2004) 0.76
Atrial septal defects in pediatric patients: noninvasive sizing with cardiovascular MR imaging. Radiology (2003) 0.76
Does fine-needle aspiration cytology optimize the surgical management of thyroid disorders in endemic goiter region? Endocr Pathol (2008) 0.75
Effects of celecoxib and ly117018 combination on human breast cancer cells in vitro. Breast Cancer (Auckl) (2009) 0.75
Suppressive activity rather than frequency of FoxP3(+) regulatory T cells is essential for CA-125-specific T-cell activation after abagovomab treatment. Hum Immunol (2010) 0.75
Differentiation of Impaired From Preserved Hemodynamics in Patients With Fontan Circulation Using Real-time Phase-velocity Cardiovascular Magnetic Resonance. J Thorac Imaging (2017) 0.75
Calibration possibilities and modifier use in ETV ICP OES determination of trace and minor elements in plant materials. Anal Bioanal Chem (2009) 0.75
Mercury contamination of rat amylin mimics vasoactivity and cytotoxic effects. Peptides (2003) 0.75
Desmopressin-induced Moschcowitz-like syndrome after treatment of uterine atonic bleeding in a 28-year-old pregnant woman: case report and overview of the literature. Blood Coagul Fibrinolysis (2011) 0.75
Influence of goal-directed therapy with balanced crystalloid-colloid or unbalanced crystalloid solution on base excess. J Int Med Res (2014) 0.75
Development of a delivery system for the continuous endogenous release of an anti-idiotypic antibody against ovarian carcinoma. Hybridoma (Larchmt) (2005) 0.75
Anti-idiotypic antibody abagovomab in advanced ovarian cancer. Future Oncol (2008) 0.75